In Santa Catarina, a rising red seaweed aquaculture sector is turning fresh coastal biomass into high-value biostimulants, positioning Brazil to develop a domestic alternative to imported products.
The production of natural algal astaxanthin – at a scale and price that make it an affordable aquafeed ingredient – is tantalisingly close, according to Claude Kaplan, CEO of Kuehnle Agro Systems (KAS)*.
A new paper details how molecular tools such as CRISPR could be effectively used to increase the resistance of Atlantic salmon to sea lice – improving fish welfare and reducing costs for the salmon farming sector.
BarAlgae, a producer of microalgal hatchery feeds for shrimp, fish and shellfish, aims to expand globally by setting up microalgae facilities in major aquaculture hubs.
SeaCrop, the Israeli startup pioneering the harvesting of marine microalgae for aquafeed, is in the process of raising funding, after making steady progress on both the technological and commercial fronts.
Fabiane Almeida, founder of Aqua Viridi, is convinced that producing Amazonian algae can help tackle environmental challenges, increase food production and create employment opportunities in the heart of the rainforest.
Disease management is one of the most persistent challenges in aquaculture and the solutions often come at a cost to both the environment and the fish themselves. But one company, Sundew, believes it’s found a game-changing natural alternative to formalin for …
Massive blooms of sargassum seaweed are choking Caribbean coastlines – threatening marine life, deterring tourism and damaging coastal economies – but where others see a threat, SOS Biotech is already turning the invasive species into valuable products.
Dr Emily Kostas, a multidisciplinary bioscientist and applied phycologist with over a decade’s experience working with seaweed, offers insights into how biorefineries work, why they matter and what challenges lie ahead.
Bacteriophages are poised to revolutionise aquaculture by significantly reducing mortality rates and antibiotic use, according to Dr Aristobulo Loaiza, CEO of Hedros Bio.
A new business opportunity which will involve the Centre for Aquaculture technologies (CAT) collaborating with Brazilian Fish to grow genome edited tilapia is a promising landmark – both for the companies and for the aquaculture industry as a whole.
AlgiSys BioSciences, which has developed a proprietary strain of microalgae for aquafeeds that’s rich in EPA omega-3 and alternative protein, is currently looking to raise $5 million to enable commercial-scale production.
Umami Bioworks is bucking the negative trends that hit the cell-cultivated meat and seafood sectors – landing significant deals with some of the biggest players in the seafood and pet food worlds.
